Silver Book Fact

Economics of DR Treatment

Fact image

Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.

Pershing S, Enns E, Matesic B, Owens D, et al. Cost-Effectiveness of Treatment of Diabetic Macular Edema. Ann Intern Med. 2014; 160(1): 160-3. http://annals.org/article.aspx?articleid=1811027

Reference

Title
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Publication
Ann Intern Med
Publication Date
2014
Authors
Pershing S, Enns E, Matesic B, Owens D, et al.
Volume & Issue
Volume 160, Issue 1
Pages
160-3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Every additional dollar spent on the overall treatment of type 2 diabetes has produced health gains valued at $1.49.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • In a community-based pharmaceutical care services program for 194 participants in 2001, days of sick time decreased at each interval (each year for 1-5 years) for one employer, with estimated…  
  • To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type…  
  • In general, for every 10 mmHg reduction in systolic blood pressure, the risk for any complication related to diabetes is reduced by 12%.